Učitavanje...
Eltrombopag: Role in Cytopenias Following Hematopoietic Stem Cell Transplantation
Eltrombopag is a small molecule oral agonist of the thrombopoietin receptor. Initially used for improving thrombocytopenia in chronic immune thrombocytopenia (ITP), it was later found to be efficacious in various other etiologies of thrombocytopenia as well as inherited marrow failure syndromes. Lat...
Spremljeno u:
| Izdano u: | Indian J Hematol Blood Transfus |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer India
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229069/ https://ncbi.nlm.nih.gov/pubmed/32425372 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-019-01194-7 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|